On Mar. 27, 2020, Luminex announced the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization…
On Mar. 26, 2020, Thermo Fisher Scientific announced it had received the CE mark in the European Union…
On Mar. 26, 2020, physician-scientists at four University of California Health medical centers — UC San Diego Health,…
On Mar. 26, 2020, iBio announced that immunization studies for its SARS-CoV-2 Virus-Like Particle program (‘IBIO-200’) were proceeding…
On Mar. 25, 2020, Quidel received CE Mark for the Lyra SARS-CoV-2 assay, authorizing Quidel to market and…
On Mar. 25, 2020, Vir Biotech announced announced that it has identified multiple human monoclonal antibody (mAb) development…
On Mar. 25, 2020, Xencor announced a technology license agreement with Vir Biotech in which Vir will have…
On Mar. 25, 2020, the Perelman School of Medicine at the University of Pennsylvania announced it had established…
On Mar. 24, 2020, to help in educating the public and in the hope of better conveying the…
On Mar. 24, 2020, Resverlogix announced a Mar. 23, 2020 bioRxiv publication that has shown apabetalone to inhibit…
On Mar. 24, 2020, PerkinElmer announced the U.S. Food and Drug Administration (FDA) had provided Emergency Use Authorization…
On Mar. 24, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, had…
On Mar. 24, 2020, Mesa Biotech announced it had received Emergency Use Authorization (EUA) from the FDA for…
On Mar. 23, 2020, Resverlogix announced that it was seeking to collaborate with organizations currently testing therapies for…
On Mar. 23, 2020, Sorrento and SmartPharm Therapeutics announced a research and development collaboration to develop a next-generation,…
On Mar. 23, 2020, researchers at Washington University School of Medicine in St. Louis announced they were investigating…
On Mar. 21, 2020, the FDA issued the first emergency use authorization for a point-of-care COVID-19 diagnostic for…
On Mar. 20, 2020, Cardax released a white paper outlining the potential role of astaxanthin in the treatment…
On Mar. 20, 2020, Bellerophon Therapeutics announced the U.S. Food and Drug Administration (FDA) had granted emergency expanded…
On Mar. 19, 2020, Abbott announced the FDA has issued Emergency Use Authorization (EUA) for the company’s molecular…
On Mar. 19, 2020, Roche announced it was working with the U.S. Food & Drug Administration (FDA) to…
On Mar. 19, 2020, Mesa Biotech announced it had been awarded a $561,000 contract from the U.S. Department…
On Mar. 19, 2020, the Mayo Clinic announced it had significantly expanded its capacity to test clinical samples…
On Mar. 19, 2020, iBio announced its progress towards developing vaccine candidates for preventing infection from the SARS-CoV-2…
On Mar. 18, 2020, scientists from the University of Oxford’s Engineering Science Department and the Oxford Suzhou Centre…
On Mar. 18, 2020, Abbott announced that the FDA had issued Emergency Use Authorization (EUA) for the company’s…
On Mar. 18, 2020, Eli Lilly announced its scientists were partnering with the Indiana State Department of Health…
On Mar. 17, 2020, the virus that causes coronavirus disease 2019 (COVID-19) was stable for several hours to…
On Mar. 17, 2020, Quidel Corp. announced it had received Emergency Use Authorization (EUA) from the U.S. Food…
On Mar. 17, 2020, scientists reported the novel SARS-CoV-2 coronavirus that emerged in the city of Wuhan, China,…